Mayer Labs to relaunch the Today Sponge
BERKELEY, Calif. Mayer Labs on Tuesday announced that it will relaunch the Today Sponge, possibly marking the fourth time the over-the-counter birth control product has been introduced to the U.S. market.
According to Mayer, the product already has distribution through CVS, Walgreens and Duane Reade, three retailers who had carried the product before.
Today Sponge was originally introduced in 1983 and removed from the market due to manufacturing problems in 1994, according to published reports. The product was reintroduced into U.S. stores in 2005 by Allendale Pharmaceuticals, which was acquired by Synova Healthcare Group in 2007. Synova “re-launched” the Today Sponge soon after it acquired Allendale, but filed for bankruptcy protection later that year. Now Mayer has acquired the manufacturing and distribution rights to the birth control product.
“We are very pleased to add the Today Sponge to our portfolio of high quality reproductive products,” stated David Mayer, CEO of Mayer Labs. “The recent interruption of distribution was not the result of product quality or consumer demand, but was due to the previous owner, Synova Healthcare Group, filing bankruptcy.”
The Today Sponge is being relaunched with new packaging and Web site. Suggested retail price for a 3-pack is $14.99.
Mosquito gut bacteria may inhibit malaria parasite, researchers say
BALTIMORE, Md. Bacteria in the gut of a mosquito may inhibit infection of Plasmodium falciparum, the parasite that causes malaria in humans, according to researchers at the Johns Hopkins Bloomberg School of Public Health.
Scientists with the Bloomberg School’s Malaria Research Institute found that removing these bacteria, or microbial flora, with antibiotics made the mosquitoes more susceptible to Plasmodium infection because of a lack of immune stimulation. Their study is published in the May 8, edition of the journal PLoS Pathogens.
“Our study suggests that the microbial flora of mosquitoes is stimulating immune activity that protects the mosquito from Plasmodium infection,” stated George Dimopoulos, senior author of the study and associate professor with Johns Hopkins Malaria Research Institute. “The same immune factors that are needed to control the mosquito’s infection from the microbes are also defending against the malaria parasite Plasmodium. … The interplay between bacteria and the mosquito’s immune system may have significant implications for the transmission of malaria in the field where mosquitoes may be exposed to different types of bacteria in different regions. Theoretically, these bacteria could be introduced to the mosquitoes to boost their immunity to the malaria parasite and make them resistant and incapable of spreading the disease. Our current research aims at identifying those bacteria that trigger the strongest mosquito immune defense against the malaria parasite.”
Malaria kills more than one million people worldwide each year; the majority of deaths are among children living in Africa.
Herb works as anti-ulcer therapy, study shows
BEIJING A research team led by Syed Rafatullah from Saudi Arabia validated the gastric anti-ulcer properties of the herb Rocket “Eruca sativa L.” (EER) on experimentally-induced gastric secretion and ulceration in albino rats. The study was published April 28 in the World Journal of Gastroenterology.
In recent years, Rocket “Eruca sativa L.” (EER), a member of the Brassicacae family, has gained greater importance as a salad vegetable and spice, especially among Middle Eastern populations and Europeans. It is believed that plants belonging to the Brassicacae family possess diversified medicinal and therapeutic properties including inhibition of tumorigenesis, anti-ulcer and hepatoprotective activities.
Although the introduction of proton-pump inhibitors to the classic anti-ulcer therapy has revolutionized treatment of peptic ulcers and other gastrointestinal disorders, there is still no complete cure for this disease, researchers noted. It has been shown that long term use of these drugs leads to various adverse and side effects. Relapses of the malady, ineffectiveness of different drug regimens and even resistance to drugs are emerging. Thus, there is an urgent requirement to identify more effective and safe anti-ulcer agents.
Researchers found that the ethanolic extract of EER significantly and dose-dependently reduced basal gastric acid secretion, titratable acidity and ruminal ulceration in lab rats. The authors concluded that EER extract possesses anti-ulcer activities against experimentally-induced gastric lesions.